Strength
.5 mg/mL
Manufacturer
Sandoz Inc.NDC
00781600078
Classification
Generic
Dosage Form
EMULSION
Route
OPHTHALMIC
Last Updated
4/22/2026
Active Ingredients
DIFLUPREDNATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA022212On Market Since
5/15/2013
Related Drugs
Same classification
No related drugs found.